Our pipeline encompasses T cell therapies targeting well-studied cancer specific antigens, onco-fetal antigens, mutated oncogenes and viral oncogenes. 

pipeline – 2.22.2018
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text.